Skip to search formSkip to main contentSkip to account menu

Alcoholic Steatohepatitis

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Elevated blood glucose and insulin resistance are triggering factors for non-alcoholic steatohepatitis (NASH). We investigated… 
2016
2016
Non-alcoholic steatohepatitis (NASH), a metabolic disorder consisting of steatosis and inflammation, is considered the hepatic… 
2012
2012
Oxidative stress is considered as a mechanism of hepatocellular injury in non‐alcoholic steatohepatitis (NASH). Pycnogenol (PYC… 
2012
2012
Thiazolidinediones (TZDs) markedly reduce hepatic steatosis in both rodents and humans. However, the effects and mechanisms of… 
2011
2011
Aim:  Non‐alcoholic steatohepatitis (NASH) may progress to liver cirrhosis, and NASH patients with liver cirrhosis are at risk of… 
2010
2010
The favorable metabolic effects of telmisartan have been attributed to its angiotensin II receptor blockade and action as a… 
2010
2010
AbstractAim:To investigate the expression of advanced glycation end products (AGEs) and their receptor RAGE in the livers and… 
2009
2009
BACKGROUND Chronic ethanol consumption coupled with folate deficiency leads to rapid liver fat accumulation and progression to… 
2008
2008
Background. Dietary fat excess and antioxidant deficiency, altered lipid metabolism, and increased lipoperoxidation have been… 
2007
2007
Objective. Non-alcoholic steatohepatitis (NASH) is a form of chronic hepatitis. The pathogenesis of NASH has been dealt with in…